Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans

S. Lilly Zheng, Jielin Sun, Yu Cheng, Ge Li, Fang Chi Hsu, Yi Zhu, Bao Li Chang, Wennuan Liu, Jin Woo Kim, Aubrey R. Turner, Marta Gielzak, Guifang Yan, Sarah D. Isaacs, Kathleen E. Wiley, Jurga Sauvageot, Huann Sheng Chen, Robin Gurganus, Leslie A. Mangold, Bruce J. Trock, Henrik GronbergDavid Duggan, John D. Carpten, Alan W. Partin, Patrick C. Walsh, Jianfeng Xu, William B. Isaacs

Research output: Contribution to journalArticlepeer-review

116 Scopus citations


Background: Recent studies have provided evidence of associations between genetic markers at human chromosome 8q24 and an increased risk of prostate cancer. We examined whether multiple independent risk variants exist in this region and whether the strength of observed associations differs as a function of disease aggressiveness. Methods: We evaluated associations between 18 single-nucleotide polymorphisms (SNPs) in a 1-Mb interval at 8q24 and the risk of prostate cancer among 1563 case patients (1017 of whom had high-grade [Gleason score ≥7] and/or non-organ-confined disease) and 576 control subjects of European American ancestry. Differences in genotype frequencies between case and control subjects were compared using logistic regression analysis, with adjustment for age, and the Wald chi-square test. All statistical tests were two-sided. Results: We identified multiple SNPs in a 50-kb region (referred to as locus 1) that are in linkage disequilibrium with a previously reported risk-associated SNP at 8q24, rs1447295, but were more strongly associated with prostate cancer risk in our study population. We also identified a novel susceptibility SNP, rs6983267, at a second locus (locus 2) that is approximately 70 kb centromeric of rs1447295 and in linkage equilibrium with, and independent of, locus 1. Risk alleles at locus 2 were common in our study population (minor allele frequency ∼50%, 25% homozygous for risk-associated allele). Analysis of the National Cancer Institute's Cancer Genetic Markers of Susceptibility (CGEMS) prostate cancer association study database alone and in combination with our data provided further evidence for this second prostate cancer risk locus; in the combined analysis, the allele frequencies for rs6983267 differed statistically significantly between case patients and control subjects (P = 1.61 × 10-9). We also identified a third locus at 8q24, approximately 400 kb centromeric to locus 2, that was statistically significantly associated with prostate cancer risk in a combined analysis of our data and CGEMS study data (P = 6.8 × 10-4). A joint analysis of loci 1 and 2 indicated that 35% of the control subjects carried risk genotypes at one or both these loci; compared with men with the nonrisk genotype at both loci, men with risk genotypes at both loci had an odds ratio of prostate cancer of 2.68 (95% confidence interval [CI] = 1.62 to 4.43) and men with risk genotypes at either locus had an odds ratio of prostate cancer of 1.70 (95% CI = 1.39 to 2.07). Conclusions: Three loci at 8q24 are independent genetic risk factors for prostate cancer.

Original languageEnglish (US)
Pages (from-to)1525-1533
Number of pages9
JournalJournal of the National Cancer Institute
Issue number20
StatePublished - Oct 2007

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans'. Together they form a unique fingerprint.

Cite this